NCT04252794View on ClinicalTrials.gov

Graft Inflow Modulation for Portal Hyper-perfusion in Live Donor Liver Transplantation

NACompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

August 8, 2019

Primary Completion Date

July 31, 2023

Study Completion Date

July 31, 2023

Conditions
Cirrhosis, Liver
Interventions
PROCEDURE

Splenic artery ligation

Splenic artery will be ligated just after takeoff from coeliac trunk at the level of body of pancreas

OTHER

No intervention

Splenic artery is not ligated despite the presence of portal hyperperfusion

Trial Locations (1)

110074

Institute of Liver and Biliary Sciences, New Delhi

All Listed Sponsors
lead

Institute of Liver and Biliary Sciences, India

OTHER

NCT04252794 - Graft Inflow Modulation for Portal Hyper-perfusion in Live Donor Liver Transplantation | Biotech Hunter | Biotech Hunter